News Releases
Welcome to our Press Releases page, where you’ll find the latest updates and announcements from Ventripoint Diagnostics Ltd. This section is dedicated to keeping you informed about our groundbreaking developments, strategic partnerships, and significant milestones. Stay connected with us as we continue to advance the field of cardiac diagnostics, ensuring you’re always in the know about our progress and achievements.
2025
February 27, 2025
Ventripoint Diagnostics Announces U.S. FDA 510(k) Clearance for VMS+TM 4.0 Automated Radiological Image Processing Software/System
January 30, 2025
Ventripoint Strengthens Sales Strategy with Global Expertise to Drive 2025 Growth
January 23, 2025
Ventripoint Provides 2025 Update and Outlook
January 17, 2025
Ventripoint Updates Submission to U.S. Food and Drug Administration for its Next Generation, AI-powered Heartscanning Technology
January 5, 2025
Ventripoint Issues Shares for Payment of Debenture Interest
2024
December 20, 2024
Ventripoint Announces Extension of Non-Brokered Convertible Debenture Private Placement
December 18, 2024
VENTRIPOINT and ASCEND Cardiovascular sign Term Sheet for integration of VMS+ into ASCEND’s Gen3Echo™ platform
December 17, 2024
Ventripoint Announces Closing of First Tranche of Amended Non-Brokered Convertible Debenture Private Placement
December 9, 2024
Ventripoint Issue Shares for Payment of Debenture Interest and Amends Terms of Convertible Debenture Offering
December 4, 2024
Ventripoint Provides Corporate Update and Announces Shareholder Teleconference
November 22, 2024
Ventripoint Announces Closing of Debt Settlement Agreements
November 19, 2024
Ventripoint Announces New Sales Program to Accelerate Growth in U.S. Market for AI-Powered Echocardiography Solutions
November 14, 2024
Ventripoint Announces Closing of Second and Final Tranche of Non- Brokered Private Placement Pursuant to Listed Issuer Financing Exemption
October 24, 2024
Ventripoint Receives EU CE Mark for Next Generation, AI-powered Heart-scanning Technology
October 15, 2024
Ventripoint Announces Extension of Private Placement Offerings and Upsize of Non-Brokered Private Placement Pursuant to Listed Issuer Financing Exemption
October 11, 2024
Ventripoint’s Next Generation, AI-powered Heart-Scanning Technology Submitted for EU Medical Device Regulation Certification
October 8, 2024
Ventripoint Announces Successful Completion of Key Quality Audits
September 30, 2024
Ventripoint Selected as Trusted Solution for Cardiac Imaging; Featured at the Take Heart Conference
September 17, 2024
Ventripoint Announces Filing Amended and Restated Offering Document for Non-Brokered Private Placement Pursuant to Listed Issuer Financing Exemption
September 9, 2024
Ventripoint Issues Option Grants and Reports Exercise of Options
August 28, 2024
Ventripoint Provides Financing Update
August 21, 2024
Ventripoint Receives Medical Device License from Health Canada to Sell Next Generation, AI-powered, Heart-scanning Technology
August 12, 2024
Ventripoint’s Next Generation, AI-powered Heart-scanning Technology Submitted to Health Canada for Medical Device License
July 30, 2024
Ventripoint Hires ERG to Provide Investor Relations Services
July 12, 2024
Ventripoint Announces Expansion of Collaboration with ASCEND Cardiovascular, a Leading Provider of Cardiovascular IT Solutions Across North America
July 2, 2024
Ventripoint Announces Closing of Second Tranche of Non-Brokered Convertible Debenture Private Placement and the Extension of the Offering
June 27, 2024
Ventripoint Announces Extension of Non-Brokered Convertible Debenture Private Placement
June 24, 2024
Ventripoint To Present Its AI-enhanced Cardiac Ultrasound Technology to B.C. and Canadian Health Care Leaders at The Data Effect
June 13, 2024
Ventripoint Welcomes Matt Dobson as Marketing Director to Guide Market Development and Product Management
June 10, 2024
Ventripoint Diagnostics Announces Shareholder Update and Teleconference
May 30, 2024
Ventripoint Commits to Fight Against Forced Labour and Child Labour in Supply Chains
May 14, 2024
Ventripoint Applies for Extension of Non-Brokered Convertible Debenture Private Placement
May 13, 2024
Ventripoint Announces Closing of First Tranche of Non-Brokered Convertible Debenture Private Placement
May 1, 2024
Duke University Health Center — One of America’s Top Heart-care Institutions and Innovators — Purchases Ventripoint’s AI Heart-scan Technology
March 04, 2024
Enhanced Design Breakthrough Makes Ventripoint’s VMS+ Even Simpler to Use
February 20, 2024
Ventripoint Successfully Showcases A.I.- Powered Heart-Scanning Technology at Prestigious International Cardiology Conferences
February 13, 2024
Ventripoint Welcomes Bart Hendriks as New Strategic Partnerships Executive to Accelerate European and Global Sales
February 13, 2024
Ventripoint Announces Changes to The Board of Directors
January 24, 2024
Dr. Luc Mertens, Head of Echocardiography at The Hospital for Sick Children, Joins Ventripoint’s Clinical Advisory Board